Philip Farrell, MD, PhD, received the George Cunningham Visionary Award in Newborn Screening from the Association of Public Health Laboratories (APHL) at the 2013 Joint Meeting of the Newborn Screening and Genetic Testing Symposium and the International Society for Neonatal Screening. The award relates to his work has that centered primarily on cystic fibrosis (CF) research, as well as racial infant mortality.
The association applauded Farrell for his role in pioneering and promoting a mutation screening process that has led to improvements in CF testing, as well as his work with Clinical Laboratory Standards Institute to develop guidance on the management and treatment of newborns diagnosed with CF.